Mkt Cap$2.17T-0.28%
24h Vol$90.12B
BTC Dom56.0%
ETH Dom8.7%
F&G12Extreme Fear
BTC$60,654.00-0.59% ETH$1,559.10-1.26% USDT$0.9996-0.01% BNB$573.34+0.04% USDC$0.9997+0.01% XRP$1.09-1.35% SOL$61.91-3.12% TRX$0.3237+0.86% FIGR_HELOC$1.03+0.46% DOGE$0.0814-0.42% HYPE$56.44-5.27% USDS$0.9997-0.02% LEO$9.44-1.44% RAIN$0.0128-1.63% XLM$0.2116+5.14% CC$0.1627+9.72% BTC$60,654.00-0.59% ETH$1,559.10-1.26% USDT$0.9996-0.01% BNB$573.34+0.04% USDC$0.9997+0.01% XRP$1.09-1.35% SOL$61.91-3.12% TRX$0.3237+0.86% FIGR_HELOC$1.03+0.46% DOGE$0.0814-0.42% HYPE$56.44-5.27% USDS$0.9997-0.02% LEO$9.44-1.44% RAIN$0.0128-1.63% XLM$0.2116+5.14% CC$0.1627+9.72%
News

market analysis

Total Stories
1,125
Section
market analysis
Why did Sonnet Therapeutic's Shares Gain over 200% in Today's Premarket Trading?
Market Analysis

Why did Sonnet BioTherapeutics (SONN) Shares Gain over 200% in Premarket Trading?

Sonnet BioTherapeutics announced an $888 million business combination to create Hyperliquid Strategies Inc, a public cryptocurrency treasury company.

Tim FriesJul 14, 20253 min read